Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Contact information

Email
rachel.dunn@oncology.ox.ac.uk

Research groups

Oncology Clinical Trials Office (OCTO)

Rachel Dunn

Clinical Trials Administrator

I joined the Oncology Clinical Trials Office (OCTO) in December 2018 as a Clinical Trials Administrator. Previously I worked within the NHS at the Warneford Hospital, and then the John Radcliffe Hospital.

Trials I am currently working on:

OCTOVA: Randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with BRCA mutated platinum-resistant ovarian cancer

Publications:

Randomised Phase II Trial of Olaparib, chemotherapy, or Olaparib and Cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol (https://www.oncology.ox.ac.uk/publications/1149973)